LNC00115 Mediates Cisplatin Resistance by Regulating the miR-7/ERK Signalling Pathway in Ovarian Cancer

LNC00115 Mediates Cisplatin Resistance by Regulating the miR-7/ERK Signalling Pathway in Ovarian Cancer

Xinyan Jiang, Yan Cheng, Yanan He, Shanshan Cong, Liyuan Sun, Di Wu, Han Wu, Guangmei Zhang The First Affiliated Hospital, Harbin Medical University, Harbin, People’s Republic of ChinaCorrespondence: Guangmei Zhang Building 2, 23 Youzheng Road, Harbin, 150001, People’s Republic o...

Full description

Bibliographic Details
Main Authors:	Jiang X, Cheng Y, He Y, Cong S, Sun L, Wu D, Wu H, Zhang G
Format:	Article
Language:	English
Published:	Dove Medical Press 2021-05-01
Series:	Cancer Management and Research
Subjects:	cisplatin resistance mir-7 lnc00115 ovarian cancer erk
Online Access:	https://www.dovepress.com/lnc00115-mediates-cisplatin-resistance-by-regulating-the-mir-7erk-sign-peer-reviewed-fulltext-article-CMAR

Similar Items

Long noncoding RNA LINC00115 promotes breast cancer metastasis by inhibiting miR‐7
by: Chunlei Yuan, et al.
Published: (2020-07-01)

Long Non-coding RNA LINC00115 Contributes to the Progression of Colorectal Cancer by Targeting miR-489-3p via the PI3K/AKT/mTOR Pathway
by: Weiyu Feng, et al.
Published: (2020-09-01)

LINC00115 promotes stemness and inhibits apoptosis of ovarian cancer stem cells by upregulating SOX9 and inhibiting the Wnt/β-catenin pathway through competitively binding to microRNA-30a
by: Rui Hou, et al.
Published: (2021-07-01)

miR-4461 Regulates the Proliferation and Metastasis of Ovarian Cancer Cells and Cisplatin Resistance
by: Lei Dou, et al.
Published: (2021-03-01)

miR-34c Targets MET to Improve the Anti-Tumor Effect of Cisplatin on Ovarian Cancer
by: Yang S, et al.
Published: (2020-04-01)

LncRNA WDFY3-AS2 promotes cisplatin resistance and the cancer stem cell in ovarian cancer by regulating hsa-miR-139-5p/SDC4 axis
by: Yue Wu, et al.
Published: (2021-05-01)

Berberine Sensitizes Human Ovarian Cancer Cells to Cisplatin Through miR-93/PTEN/Akt Signaling Pathway
by: Qiaoyun Chen, et al.
Published: (2015-06-01)

LncRNA MALAT1 Regulates the Progression and Cisplatin Resistance of Ovarian Cancer Cells via Modulating miR-1271-5p/E2F5 Axis
by: Wang Y, et al.
Published: (2020-10-01)

miR-199a modulates cisplatin resistance in ovarian cancer by targeting Hif1α
by: Feng X, et al.
Published: (2017-12-01)

Modelling and control of non-linear systems using state-dependent parameter (SDP) models and proportional-integral-plus (PIP) control method
by: Sadeghi, Jafar
Published: (2006)

Formal verification of implementations of stateflow charts
by: Miyazawa, Alvaro Heiji
Published: (2012)

HOTTIP-miR-205-ZEB2 Axis Confers Cisplatin Resistance to Ovarian Cancer Cells
by: Yu-Jie Dong, et al.
Published: (2021-07-01)

Recovery of miR-139-5p in Ovarian Cancer Reverses Cisplatin Resistance by Targeting C-Jun
by: Ying Jiang, et al.
Published: (2018-11-01)

LncRNA BANCR Attenuates the Killing Capacity of Cisplatin on Gastric Cancer Cell Through the ERK1/2 Pathway
by: Miao X, et al.
Published: (2021-01-01)

GRHL2 Upregulation Predicts a Poor Prognosis and Promotes the Resistance of Serous Ovarian Cancer to Cisplatin
by: Nie Y, et al.
Published: (2020-06-01)

NEAT1 Knockdown Suppresses the Cisplatin Resistance in Ovarian Cancer by Regulating miR-770-5p/PARP1 Axis
by: Zhu M, et al.
Published: (2020-08-01)

LncRNA NEAT1 contributes to paclitaxel resistance of ovarian cancer cells by regulating ZEB1 expression via miR-194
by: An J, et al.
Published: (2017-11-01)

Knockdown Of lncRNA NCK-AS1 Regulates Cisplatin Resistance Through Modulating miR-137 In Osteosarcoma Cells
by: Cheng Y, et al.
Published: (2019-12-01)

miR-205-5p Mediated Downregulation of PTEN Contributes to Cisplatin Resistance in C13K Human Ovarian Cancer Cells
by: Xiaoyan Shi, et al.
Published: (2018-11-01)

LncRNA HOTAIR Regulates CCND1 and CCND2 Expression by Sponging miR-206 in Ovarian Cancer
by: Lei Chang, et al.
Published: (2018-09-01)

MiR‐335‐5p restores cisplatin sensitivity in ovarian cancer cells through targeting BCL2L2
by: Ruonan Liu, et al.
Published: (2018-09-01)

PCAT-1 contributes to cisplatin resistance in gastric cancer through miR-128/ZEB1 axis
by: Yinmou Guo, et al.
Published: (2019-10-01)

LINC00184 Promotes Ovarian Cancer Cells Proliferation and Cisplatin Resistance by Elevating CNTN1 Expression via Sponging miR-1305
by: Han Y, et al.
Published: (2021-04-01)

MiR-140 Resensitizes Cisplatin-Resistant NSCLC Cells to Cisplatin Treatment Through the SIRT1/ROS/JNK Pathway
by: Lin Z, et al.
Published: (2020-08-01)

MiR-3168, miR-6125, and miR-4718 as potential predictors of cisplatin-induced nephrotoxicity in patients with head and neck cancer
by: Julia C. F. Quintanilha, et al.
Published: (2021-05-01)

Exosome-Mediated Transfer of lncRNA HOTTIP Promotes Cisplatin Resistance in Gastric Cancer Cells by Regulating HMGA1/miR-218 Axis
by: Wang J, et al.
Published: (2019-12-01)

LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression
by: Haihai Liang, et al.
Published: (2018-08-01)

Restoration of miR-26b expression partially reverses the cisplatin resistance of NSCLC by targeting tafazzin
by: Zang S, et al.
Published: (2019-09-01)

Inhibition of TRIM32 Induced by miR-519d Increases the Sensitivity of Colorectal Cancer Cells to Cisplatin
by: Su X, et al.
Published: (2020-01-01)

MiR-222 Targeted PUMA to Improve Sensitization of UM1 Cells to Cisplatin
by: Fangfang Jiang, et al.
Published: (2014-12-01)

LncRNA MEG3 suppressed the progression of ovarian cancer via sponging miR-30e-3p and regulating LAMA4 expression
by: Yang Liu, et al.
Published: (2020-05-01)

LncRNA-ATB Promotes Cisplatin Resistance in Lung Adenocarcinoma Cells by Targeting the miR-200a/β-Catenin Pathway
by: Tang W, et al.
Published: (2020-03-01)

LncRNA FLVCR1-AS1 mediates miR-513/YAP1 signaling to promote cell progression, migration, invasion and EMT process in ovarian cancer
by: Huan Yan, et al.
Published: (2019-08-01)

Suppressing miR-199a-3p by promoter methylation contributes to tumor aggressiveness and cisplatin resistance of ovarian cancer through promoting DDR1 expression
by: Yuao Deng, et al.
Published: (2017-07-01)

LncRNA HOTTIP Participates in Cisplatin Resistance of Tumor Cells by Regulating miR-137 Expression in Pancreatic Cancer
by: Yin F, et al.
Published: (2020-04-01)

MiR-129-5p Suppresses Cell Proliferation of Human Osteosarcoma Cancer by Down-Regulating LncRNA Lnc712
by: Yu Y, et al.
Published: (2021-03-01)

BNIP3 contributes to cisplatin‐induced apoptosis in ovarian cancer cells
by: Jinghui Jia, et al.
Published: (2020-08-01)

Loganin Attenuates the Severity of Acute Kidney Injury Induced by Cisplatin through the Inhibition of ERK Activation in Mice
by: Dong-Uk Kim, et al.
Published: (2021-01-01)

Propofol suppresses cell viability, cell cycle progression and motility and induces cell apoptosis of ovarian cancer cells through suppressing MEK/ERK signaling via targeting circVPS13C/miR-145 axis
by: Huan Lu, et al.
Published: (2021-02-01)

A Chemotherapy-Driven Increase in Mcl-1 Mediates the Effect of miR-375 on Cisplatin Resistance in Osteosarcoma Cells
by: Liu A, et al.
Published: (2019-12-01)

Cannot write session to /tmp/vufind_sessions/sess_1nbbgh7f1lkoml1kqnsasurj1q